Page last updated: 2024-08-21

cyclopentane and Adverse Drug Event

cyclopentane has been researched along with Adverse Drug Event in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukui, M; Hata, A; Marumo, S; Takamatsu, K	1
Akashi-Ueda, R; Hata, A; Matsumura, T; Takamatsu, K	1
Birnkrant, D; Boucher, R; Camilli, S; Carter, W; Chan, I; Dal Pan, G; Dallas, S; Francis, H; Gada, N; Goodman, J; Jones, SC; Kosko, R; Scales, T; Sorbello, A; Struble, K; Thompson, E; Truffa, M	1

Reviews

1 review(s) available for cyclopentane and Adverse Drug Event

Article	Year
Safety and efficacy of peramivir for influenza treatment. Drug design, development and therapy, 2014, Volume: 8 Topics: Acids, Carbocyclic; Cyclopentanes; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Guanidines; Humans; Influenza, Human	2014

Other Studies

2 other study(ies) available for cyclopentane and Adverse Drug Event

Article	Year
Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017, Volume: 50, Issue:4 Topics: Acids, Carbocyclic; Administration, Intravenous; Aged; Aged, 80 and over; Antiviral Agents; Cyclopentanes; Drug-Related Side Effects and Adverse Reactions; Female; Guanidines; Humans; Influenza, Human; Male; Retrospective Studies; Treatment Outcome	2017
Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:1 Topics: Acids, Carbocyclic; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Cyclopentanes; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Guanidines; Hospitalization; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Pregnancy; Risk Factors; United States; United States Food and Drug Administration	2012

Article

Year

Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017, Volume: 50, Issue:4

Topics: Acids, Carbocyclic; Administration, Intravenous; Aged; Aged, 80 and over; Antiviral Agents; Cyclopentanes; Drug-Related Side Effects and Adverse Reactions; Female; Guanidines; Humans; Influenza, Human; Male; Retrospective Studies; Treatment Outcome

2017

Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:1

Topics: Acids, Carbocyclic; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Cyclopentanes; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Guanidines; Hospitalization; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Pregnancy; Risk Factors; United States; United States Food and Drug Administration

2012